comparemela.com

Latest Breaking News On - Essential gene exon knock in - Page 1 : comparemela.com

Editas Medicine Announces First Quarter 2023 Results and Business Updates

Company to provide a clinical update on the EDIT-301 Phase 1/2 RUBY trial for SCD in June at the European Hematology Association Congress and in a Company-sponsored webinar On track to dose 20. | May 5, 2023

United kingdomUnited statesNew yorkLas vegasLinea aspesiGemma reeveVivo hemoglobinopathiesGilmore oneillEuropean hematology associationBusiness development other corporateShoreline biosciences incExchange commissionBroad instituteHarvard university casDrug administrationHealth care conference

Editas Medicine Announces Fourth Quarter and Full Year 2022

Commenced parallel patient dosing in the EDIT-301 RUBY trial for SCD, following clinical proof-of-concept demonstrated last quarter On track to provide.

United statesUnited kingdomHarvard universityVivo hemoglobinopathiesGilmore oneillBristol myers squibbCristi barnettRon moldaverBroad instituteHarvard university casHealth care conferenceBroad institute casBusiness development other corporateExchange commissionEditas medicine incGilmoreo neill

Why Editas Medicine Stock Charged Higher in January

The genome-editing company's shares spiked following a definitive agreement with Shoreline Biosciences last month.

Editas medicineShoreline biosciencesEssential gene exon knock inWall street

Editas Medicine (EDIT) Sells iNK Cell Franchise to Shoreline Biosciences

Editas Medicine (EDIT) Sells iNK Cell Franchise to Shoreline Biosciences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kleanthisg xanthopoulosGilmore oneillEditas medicine incEvercore groupShoreline biosciencesEditas medicineEssential gene exon knock inGilmoreo neillChief executive officer

Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

District of columbiaUnited statesUnited kingdomMarks shearmanCristi barnettRon moldaverExchange commissionEditas medicine incMeeting of the american society geneExon knock inNew gene editing technologiesApplications sessionAnnual meetingAmerican societyCell therapyExecutive vice president

vimarsana © 2020. All Rights Reserved.